Arax Advisory Partners’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159K Buy
4,059
+3,922
+2,863% +$146K ﹤0.01% 2409
2026
Q1
$5.4K Sell
137
-251
-65% -$11.9K ﹤0.01% 2743
2025
Q4
$17.5K Sell
388
-1,855
-83% -$85.8K ﹤0.01% 2194
2025
Q3
$100K Buy
2,243
+2,014
+879% +$96.4K ﹤0.01% 1540
2025
Q2
$11K Buy
+229
New +$9.96K ﹤0.01% 1916
2025
Q1
Sell
-161
Closed -$7.39K 2967
2024
Q4
$7.39K Sell
161
-81
-33% -$3.63K ﹤0.01% 1597
2024
Q3
$11.3K Hold
242
﹤0.01% 1354
2024
Q2
$10.2K Buy
+242
New +$10.6K ﹤0.01% 1264

Other funds holding QGEN

Arax Advisory Partners's QGEN Position: Q2 2026 in Review

Arax Advisory Partners increased its Qiagen (QGEN) stake by 2,863% in Q2 2026, buying an estimated $146K and bringing the position to 4,059 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #2409.

Arax Advisory Partners first reported a position in QGEN in Q2 2024 and has held it in 8 quarters since. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Arax Advisory Partners held 4,059 shares of Qiagen worth $159K as of Q2 2026.
  • Arax Advisory Partners bought 3,922 Qiagen shares in Q2 2026, an estimated $146K.
  • Qiagen made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2409 holding.
  • Arax Advisory Partners first reported a position in Qiagen in Q2 2024 and has held it in 8 quarters since.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.